海外の治験の状況「1」での検索結果
7748件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment
- Diabetes Mellitus;Diabetes Mellitus;Diabetes Mellitus;Diabetes Mellitus
- Germany
- 2013-07-11
Not recruiting
- Interleukin-1 Receptor Antagonist and Insulin Sensitivity
- Diabetes Mellitus, Type 2;Insulin Resistance
- Netherlands
- 2009-06-25
Not recruiting
- Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36
- Anti Obesity Agent
- Switzerland
- 2009-01-13
Not Recruiting
- Can an interleukin-1 receptor antagonist reduce inflammation following subarachnoid haemorrhage?
- Subarachnoid haemorrhage Circulatory System Subarachnoid haemorrhage
- United Kingdom
- 2011-06-28
Not recruiting
- TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist Therapy
- Diabetes Mellitus, Type 2
- Czech Republic, Germany, Romania
- 2011-02-23
Not recruiting
- GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans
- Functional Gastrointestinal Disorders
- Sweden
- 2016-03-06
Not Recruiting
- Investigation of the effect of GLP-1 and left ventricular function during myocardial ischaemia
- Topic: Cardiovascular; Subtopic: Cardiovascular (all Subtopics); Disease: Cardiovascular Circulatory System Myocardial ischaemia
- United Kingdom
- 2010-05-19
Not recruiting
- GLP-1 and Microvascular Function in Type 2 Diabetes
- Type 2 Diabetes;Type 2 Diabetes;Type 2 Diabetes;Type 2 Diabetes
- United Kingdom
- 2012-11-22
Not Recruiting
- Effects of Linagliptin on active GLP-1 concentrations in subjects with renal impairment
- Type 2 diabetes mellitus MedDRA version: 18.0 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Germany
- 2013-04-22
Not recruiting
- GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake
- Obesity;Adiposity;Type 2 Diabetes
- Denmark
- 2015-10-31